Endocrine-disrupting chemicals: an Endocrine Society scientific statement
E Diamanti-Kandarakis, JP Bourguignon… - Endocrine …, 2009 - academic.oup.com
There is growing interest in the possible health threat posed by endocrine-disrupting
chemicals (EDCs), which are substances in our environment, food, and consumer products …
chemicals (EDCs), which are substances in our environment, food, and consumer products …
Polycystic ovary syndrome: an evolutionary adaptation to lifestyle and the environment
Polycystic ovary syndrome (PCOS) is increasingly recognized as a complex metabolic
disorder that manifests in genetically susceptible women following a range of negative …
disorder that manifests in genetically susceptible women following a range of negative …
Endocrine disrupting chemicals in polycystic ovary syndrome: the relevant role of the theca and granulosa cells in the pathogenesis of the ovarian dysfunction
M Jozkowiak, H Piotrowska-Kempisty, D Kobylarek… - Cells, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is the most common heterogeneous endocrine disorder
among women of reproductive age. The pathogenesis of PCOS remains elusive; however …
among women of reproductive age. The pathogenesis of PCOS remains elusive; however …
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome
Polycystic ovarian morphology is seen on ultrasound in approximately 22% of women.
Polycystic ovary syndrome (PCOS) is a common and perplexing endocrine disorder of …
Polycystic ovary syndrome (PCOS) is a common and perplexing endocrine disorder of …
Molecular mechanisms of insulin resistance in polycystic ovary syndrome
E Diamanti-Kandarakis, AG Papavassiliou - Trends in molecular medicine, 2006 - cell.com
Polycystic ovary syndrome (PCOS) is a common endocrinopathy of unknown aetiology that
affects women of reproductive age. During the past ten years, defective insulin activity in …
affects women of reproductive age. During the past ten years, defective insulin activity in …
Pathophysiology and types of dyslipidemia in PCOS
E Diamanti-Kandarakis, AG Papavassiliou… - Trends in Endocrinology …, 2007 - cell.com
Polycystic ovary syndrome (PCOS) is an endocrinopathy that affects women of reproductive
age. PCOS shares components with the metabolic syndrome and has broad health …
age. PCOS shares components with the metabolic syndrome and has broad health …
Oxidative stress in polycystic ovary syndrome
O Papalou, V M. Victor… - Current pharmaceutical …, 2016 - benthamdirect.com
Backgrouund: Polycystic ovary syndrome is a multifaceted disorder with a pathogenetic
pathway that is not fully understood yet. Apart from hormonal derangements, insulin …
pathway that is not fully understood yet. Apart from hormonal derangements, insulin …
Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
E Palioura, E Diamanti-Kandarakis - Reviews in Endocrine and Metabolic …, 2015 - Springer
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of unclear etiopathogenesis
that is likely to involve genetic and environmental components synergistically contributing to …
that is likely to involve genetic and environmental components synergistically contributing to …
Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications
OB Christiansen, R Steffensen, HS Nielsen… - Gynecologic and …, 2008 - karger.com
A considerable proportion of recurrent miscarriage (RM) cases are caused by recurrent
chromosomally abnormal conceptions. However, in younger patients and patients with …
chromosomally abnormal conceptions. However, in younger patients and patients with …
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation
Ovarian stimulation is applied in the clinic to restore mono-ovulatory cycles in anovulatory
women (ovulation induction) or to induce the development of multiple dominant follicles for …
women (ovulation induction) or to induce the development of multiple dominant follicles for …